Results 31 to 40 of about 48,282 (202)

Characterisation of carbapenem-resistant Gram-negative organisms from clinical specimens in Yola, Nigeria

Journal of Global Antimicrobial Resistance, 2020
Objectives: This study aimed to identify carbapenem-resistant Gram-negative bacteria from clinical specimens of patients in Yola, Nigeria. Methods: Routine clinical specimens were screened for the presence of carbapenem-resistant Gram-negative bacteria ...
Shuwaram A. Shettima, Isabella A. Tickler, Caitlin M. dela Cruz, Fred C. Tenover   +3 more
doaj   +1 more source

Aminoglycoside-modifying Enzymes in Carbapenem-resistant Pseudomonas aeruginosa Clinical Isolates

Mediterranean Journal of Infection, Microbes and Antimicrobials, 2022
Introduction: Aminoglycosides are the drug of choice for the treatment of Pseudomonas aeruginosa infections. Aminoglycoside resistance in P. aeruginosa often occurred via acquired aminoglycoside-modifying enzymes (AMEs).
Yeliz TANRIVERDİ ÇAYCI, Osman Sezer CİRİT, İlknur BIYIK, Canberk ÇINAR, Demet GÜR VURAL, Kemal BİLGİN, Asuman BİRİNCİ   +6 more
doaj   +1 more source

Molecular characteristics and antimicrobial resistance profiles of Carbapenem-Resistant Klebsiella pneumoniae isolates at a tertiary hospital in Nanning, China

BMC Microbiology, 2023
Purpose Carbapenem resistant Klebsiella pneumoniae is associated with nosocomial infections and can cause high mortality, which poses great threat to human health.
Xianzhen Wei, Qiuxiang Li, Yu He, Linlin Li, Shan Li, Taijie Li   +5 more
doaj   +1 more source

Genome-wide identification of carbapenem-resistant Gram-negative bacterial (CR-GNB) isolates retrieved from hospitalized patients in Bihar, India

Scientific Reports, 2022
Carbapenemase-producing clinical isolates are becoming more common over the world, posing a severe public health danger, particularly in developing nations like India.
Namrata Kumari, Mukesh Kumar, Amit Katiyar, Abhay Kumar, Pallavi Priya, Bablu Kumar, Nihar Ranjan Biswas, Punit Kaur   +7 more
doaj   +1 more source

A global perspective on the convergence of hypervirulence and carbapenem resistance in Klebsiella pneumoniae

Journal of Global Antimicrobial Resistance, 2021
Hypervirulence and carbapenem resistance have emerged as two distinct evolutionary directions for Klebsiella pneumoniae, which pose a great threat in clinical settings.
Peng Lan, Yan Jiang, Jiancang Zhou, Yunsong Yu   +3 more
doaj   +1 more source

Carbapenem-Resistant Enterobacteriaceae: Epidemiology and Prevention [PDF]

Clinical Infectious Diseases, 2011
Over the past 10 years, dissemination of Klebsiella pneumoniae carbapenemase (KPC) has led to an increase in the prevalence of carbapenem-resistant Enterobacteriaceae (CRE) in the United States. Infections caused by CRE have limited treatment options and have been associated with high mortality rates. In the previous year, other carbapenemase subtypes,
Neil, Gupta, Brandi M, Limbago, Jean B, Patel, Alexander J, Kallen   +3 more
openaire   +2 more sources

Evaluation of Resistance Mechanisms in Carbapenem-Resistant Enterobacteriaceae.

Infection and drug resistance, 2020
Carbapenem-resistant Enterobacteriaceae (CRE) is a major concern leading to morbidity and mortality in the world. CRE often is becoming a cause of therapeutic failure in both hospital and community-acquired infections.This study aimed to investigate the resistance mechanisms of CRE by phenotypic and molecular methods.Sixty CRE (50 Klebsiella pneumoniae,
Alizadeh,Naser, Ahangarzadeh Rezaee,Mohammad, Samadi Kafil,Hossein, Hasani,Alka, Soroush Barhaghi,Mohammad Hossein, Milani,Morteza, Yeganeh Sefidan,Fatemeh, Memar,Mohammad Yousef, Lalehzadeh,Aidin, Ghotaslou,Reza   +9 more
openaire   +4 more sources

Carbapenem-Resistant Enterobacteriaceae Infections in Children [PDF]

Current Infectious Disease Reports, 2015
Carbapenem-resistant Enterobacteriaceae (CRE) are an emerging global public health threat. Infections due to CRE are associated with significant morbidity and mortality. Few therapeutic options are available for treatment of these infections, and optimal antibiotic treatment regimens are unclear.
Kathleen, Chiotos, Jennifer H, Han, Pranita D, Tamma   +2 more
openaire   +2 more sources

Monooxygenases and Antibiotic Resistance: A Focus on Carbapenems

Biology, 2023
Carbapenems are a group of broad-spectrum beta-lactam antibiotics that in many cases are the last effective defense against infections caused by multidrug-resistant bacteria, such as some strains of Klebsiella pneumoniae, Escherichia coli, Pseudomonas aeruginosa, and Acinetobacter baumannii.
Minerdi, Daniela, Loqui, Davide, Sabbatini, Paolo   +2 more
openaire   +4 more sources

Concomitant Carbapenem and Colistin Resistance among Escherichia coli and Klebsiella pneumoniae Isolates from Patients Visiting a Hospital in Haryana, India

Medical Journal of Dr. D.Y. Patil Vidyapeeth, 2023
Background: Increasing prevalence of carbapenem resistance among Enterobacterales, particularly Escherichia coli and Klebsiella pneumoniae, poses a serious public health threat globally.
Leimapokpam Sumitra Devi, Moumita Sardar, Mukesh Sharma   +2 more
doaj   +1 more source